DESTEMONA BOZHANI: Open Payments
NPI 1801493275 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 10 payments from 8 companies in 2025. Trend: 2023 $707 · 2024 $695 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $188 |
| UCB, Inc. | 2 | $30 |
| JAZZ PHARMACEUTICALS INC. | 1 | $25 |
| MDD US Operations, LLC | 1 | $25 |
| Neurelis, Inc. | 1 | $24 |
| Biogen, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
Products named: AIRSUPRA, XYWAV, Gocovri, VALTOCO, TYSABRI, INGREZZA, Fintepla, AMVUTTRA.
Industry payments across MO — which companies pay providers there.
